Exelixis Inc Restructuring Charges
Exelixis Inc (EXEL) reported Restructuring Charges of $20.51 million for the 12-month period ending 2026-01-02, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-02-10
- Exelixis Inc restructuring charges for the quarter ending 2026-01-02 was $694.00K, a 173.23% increase year-over-year.
- Exelixis Inc restructuring charges for the quarter ending 2025-10-03 was $19.82M, a 20541.67% increase year-over-year.
- Exelixis Inc restructuring charges for the quarter ending 2025-07-04 was $0.00, a 100.00% decline year-over-year.
- Exelixis Inc restructuring charges for the quarter ending 2025-04-04 was $0.00, a 100.00% decline year-over-year.
- Exelixis Inc restructuring charges for fiscal 2026 was $20.51M, a 39.07% decline from fiscal 2025.
- Exelixis Inc restructuring charges for fiscal 2025 was $33.66M.
- Exelixis Inc restructuring charges for fiscal 2023 was $0.00.
- Exelixis Inc restructuring charges for fiscal 2022 was $0.00.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month | Restructuring Charges 30 month | Restructuring Charges 33 month | Restructuring Charges 36 month | Restructuring Charges 45 month | Restructuring Charges 46 month | Restructuring Charges 49 month | Restructuring Charges 52 month | Restructuring Charges 82 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $20.51M derived: sum of 2 quarters · filed 2026-02-10 | $20.51M derived: sum of 3 quarters · filed 2026-02-10 | $20.51M 10-K · filed 2026-02-10 | |||||||||
| 2025-10-03 | $19.82M 10-Q · filed 2025-11-04 | $19.82M derived: sum of 2 quarters · filed 2025-11-04 | $19.82M 10-Q · filed 2025-11-04 | $20.07M derived: sum of 4 quarters · filed 2026-02-10 | |||||||||
| 2025-07-04 | $0.00 10-Q · filed 2025-07-28 | $0.00 10-Q · filed 2025-07-28 | $254.00K derived: sum of 3 quarters · filed 2026-02-10 | $350.00K derived: sum of 4 quarters · filed 2026-02-10 | |||||||||
| 2025-04-04 | $0.00 10-Q · filed 2025-05-13 | $254.00K derived: sum of 2 quarters · filed 2026-02-10 | $350.00K derived: sum of 3 quarters · filed 2026-02-10 | $825.00K derived: sum of 4 quarters · filed 2026-02-10 | |||||||||
| 2025-01-03 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $350.00K derived: sum of 2 quarters · filed 2026-02-10 | $825.00K derived: sum of 3 quarters · filed 2026-02-10 | $33.66M 10-K · filed 2026-02-10 | |||||||||
| 2024-09-27 | $96.00K 10-Q · filed 2025-11-04 | $571.00K derived: sum of 2 quarters · filed 2025-11-04 | $33.41M 10-Q · filed 2025-11-04 | $33.41M derived: sum of 4 quarters · filed 2026-02-10 | |||||||||
| 2024-06-28 | $475.00K 10-Q · filed 2025-07-28 | $33.31M 10-Q · filed 2025-07-28 | $33.31M derived: sum of 3 quarters · filed 2026-02-10 | $33.31M derived: sum of 4 quarters · filed 2026-02-10 | |||||||||
| 2024-03-29 | $32.84M 10-Q · filed 2025-05-13 | $32.84M derived: sum of 2 quarters · filed 2026-02-10 | $32.84M derived: sum of 3 quarters · filed 2026-02-10 | $32.84M derived: sum of 4 quarters · filed 2026-02-10 | |||||||||
| 2023-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $0.00 derived: sum of 2 quarters · filed 2026-02-10 | $0.00 derived: sum of 3 quarters · filed 2026-02-10 | $0.00 10-K · filed 2026-02-10 | |||||||||
| 2023-09-29 | $0.00 10-Q · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | ||||||||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | |||||||||||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-30 | ||||||||||||
| 2022-12-30 | $0.00 10-K · filed 2025-02-11 | ||||||||||||
| 2018-12-28 | $0.00 10-K · filed 2019-02-22 | ||||||||||||
| 2017-12-29 | -$32.00K 10-K · filed 2019-02-22 | ||||||||||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-01 | -$60.00K derived: sum of 2 quarters · filed 2017-11-01 | -$32.00K 10-Q · filed 2017-11-01 | $11.00K derived: sum of 4 quarters · filed 2017-11-01 | |||||||||
| 2017-06-30 | -$60.00K 10-Q · filed 2017-08-02 | -$32.00K 10-Q · filed 2017-08-02 | $11.00K derived: sum of 3 quarters · filed 2017-08-02 | -$233.00K derived: sum of 4 quarters · filed 2017-11-01 | |||||||||
| 2017-03-31 | $28.00K 10-Q · filed 2017-05-01 | $71.00K derived: sum of 2 quarters · filed 2017-05-01 | -$173.00K derived: sum of 3 quarters · filed 2017-11-01 | $848.00K derived: sum of 4 quarters · filed 2017-11-01 | |||||||||
| 2016-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$201.00K derived: sum of 2 quarters · filed 2017-11-01 | $820.00K derived: sum of 3 quarters · filed 2017-11-01 | $914.00K 10-K · filed 2017-02-27 | $62.83M 10-K · filed 2017-02-27 | ||||||||
| 2016-12-30 | $914.00K 10-K · filed 2019-02-22 | ||||||||||||
| 2016-09-30 | -$244.00K 10-Q · filed 2017-11-01 | $777.00K derived: sum of 2 quarters · filed 2017-11-01 | $871.00K 10-Q · filed 2017-11-01 | $771.00K derived: sum of 4 quarters · filed 2017-11-01 | |||||||||
| 2016-06-30 | $1.02M 10-Q · filed 2017-08-02 | $1.11M 10-Q · filed 2017-08-02 | $1.01M derived: sum of 3 quarters · filed 2017-08-02 | $1.30M derived: sum of 4 quarters · filed 2017-08-02 | |||||||||
| 2016-03-31 | $94.00K 10-Q · filed 2017-05-01 | -$6.00K derived: sum of 2 quarters · filed 2017-05-01 | $276.00K derived: sum of 3 quarters · filed 2017-05-01 | $1.57M derived: sum of 4 quarters · filed 2017-05-01 | |||||||||
| 2016-01-01 | $1.04M 10-K · filed 2018-02-26 | ||||||||||||
| 2015-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $182.00K derived: sum of 2 quarters · filed 2017-02-27 | $1.47M derived: sum of 3 quarters · filed 2017-02-27 | $1.04M 10-K · filed 2017-02-27 | |||||||||
| 2015-09-30 | $282.00K 10-Q · filed 2016-11-03 | $1.57M derived: sum of 2 quarters · filed 2016-11-03 | $1.14M 10-Q · filed 2016-11-03 | $4.60M derived: sum of 4 quarters · filed 2017-02-27 | |||||||||
| 2015-06-30 | $1.29M 10-Q · filed 2016-08-03 | $860.00K 10-Q · filed 2016-08-03 | $4.32M derived: sum of 3 quarters · filed 2017-02-27 | $8.08M derived: sum of 4 quarters · filed 2017-02-27 | |||||||||
| 2015-03-31 | -$431.00K 10-Q · filed 2016-05-04 | $3.03M derived: sum of 2 quarters · filed 2017-02-27 | $6.79M derived: sum of 3 quarters · filed 2017-02-27 | $7.12M derived: sum of 4 quarters · filed 2017-02-27 | |||||||||
| 2014-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $7.22M derived: sum of 2 quarters · filed 2017-02-27 | $7.55M derived: sum of 3 quarters · filed 2017-02-27 | $7.60M 10-K · filed 2017-02-27 | |||||||||
| 2014-09-30 | $3.76M 10-Q · filed 2015-11-10 | $4.09M derived: sum of 2 quarters · filed 2015-11-10 | $4.13M 10-Q · filed 2015-11-10 | $4.50M derived: sum of 4 quarters · filed 2016-02-29 | |||||||||
| 2014-06-30 | $331.00K 10-Q · filed 2015-08-11 | $377.00K 10-Q · filed 2015-08-11 | $743.00K derived: sum of 3 quarters · filed 2016-02-29 | $880.00K derived: sum of 4 quarters · filed 2016-02-29 | $53.70M 10-Q · filed 2014-07-31 | ||||||||
| 2014-03-31 | $46.00K 10-Q · filed 2015-04-30 | $412.00K derived: sum of 2 quarters · filed 2016-02-29 | $549.00K derived: sum of 3 quarters · filed 2016-02-29 | $1.16M derived: sum of 4 quarters · filed 2016-02-29 | $53.30M 10-Q · filed 2014-05-01 | ||||||||
| 2013-12-31 | $366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $503.00K derived: sum of 2 quarters · filed 2016-02-29 | $1.11M derived: sum of 3 quarters · filed 2016-02-29 | $1.23M 10-K · filed 2016-02-29 | $53.30M 10-K · filed 2014-02-20 | ||||||||
| 2013-09-30 | $137.00K 10-Q · filed 2014-11-04 | $746.00K derived: sum of 2 quarters · filed 2014-11-04 | $865.00K 10-Q · filed 2014-11-04 | $8.33M derived: sum of 4 quarters · filed 2015-03-02 | $52.90M 10-Q · filed 2013-10-30 | ||||||||
| 2013-06-30 | $609.00K 10-Q · filed 2014-07-31 | $728.00K 10-Q · filed 2014-07-31 | $8.20M derived: sum of 3 quarters · filed 2015-03-02 | $8.93M derived: sum of 4 quarters · filed 2015-03-02 | |||||||||
| 2013-03-31 | $119.00K 10-Q · filed 2014-05-01 | $7.59M derived: sum of 2 quarters · filed 2015-03-02 | $8.32M derived: sum of 3 quarters · filed 2015-03-02 | $9.48M derived: sum of 4 quarters · filed 2015-03-02 | |||||||||
| 2012-12-31 | $7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $8.20M derived: sum of 2 quarters · filed 2015-03-02 | $9.37M derived: sum of 3 quarters · filed 2015-03-02 | $9.17M 10-K · filed 2015-03-02 | $52.10M 10-K · filed 2013-02-21 | ||||||||
| 2012-09-30 | $733.00K 10-Q · filed 2013-10-30 | $1.90M derived: sum of 2 quarters · filed 2013-10-30 | $1.70M 10-Q · filed 2013-10-30 | $5.65M derived: sum of 4 quarters · filed 2014-02-20 | $44.60M 10-Q · filed 2012-11-07 | ||||||||
| 2012-06-30 | $1.17M 10-Q · filed 2013-08-06 | $971.00K 10-Q · filed 2013-08-06 | $4.92M derived: sum of 3 quarters · filed 2014-02-20 | $7.85M derived: sum of 4 quarters · filed 2014-02-20 | $43.90M 10-Q · filed 2012-08-02 | ||||||||
| 2012-03-31 | -$195.00K 10-Q · filed 2013-05-07 | $3.75M derived: sum of 2 quarters · filed 2014-02-20 | $6.69M derived: sum of 3 quarters · filed 2014-02-20 | $5.17M derived: sum of 4 quarters · filed 2014-02-20 | |||||||||
| 2011-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $6.88M derived: sum of 2 quarters · filed 2014-02-20 | $5.37M derived: sum of 3 quarters · filed 2014-02-20 | $10.14M 10-K · filed 2014-02-20 | |||||||||
| 2011-09-30 | $2.94M 10-Q · filed 2012-11-07 | $1.42M derived: sum of 2 quarters · filed 2012-11-07 | $6.19M 10-Q · filed 2012-11-07 | $13.09M derived: sum of 4 quarters · filed 2012-11-07 | |||||||||
| 2011-06-30 | -$1.51M 10-Q · filed 2012-08-02 | $3.25M 10-Q · filed 2012-08-02 | $10.15M derived: sum of 3 quarters · filed 2012-08-02 | $10.49M derived: sum of 4 quarters · filed 2012-08-02 | |||||||||
| 2011-03-31 | $4.77M 10-Q · filed 2012-05-03 | $11.67M derived: sum of 2 quarters · filed 2012-05-03 | $12.01M derived: sum of 3 quarters · filed 2012-05-03 | $21.41M derived: sum of 4 quarters · filed 2012-05-03 | |||||||||
| 2010-12-31 | $6.90M 10-K · filed 2012-02-22 | $7.24M derived: sum of 2 quarters · filed 2012-02-22 | $16.64M derived: sum of 3 quarters · filed 2012-02-22 | $32.74M 10-K · filed 2014-02-20 | |||||||||
| 2010-09-30 | $339.00K 10-Q · filed 2011-10-27 | $9.74M derived: sum of 2 quarters · filed 2012-02-22 | $25.82M 10-Q · filed 2011-10-27 | ||||||||||
| 2010-06-30 | $9.40M 10-K · filed 2012-02-22 | $9.42M 10-Q · filed 2011-08-04 | $25.48M 10-Q · filed 2011-08-04 | ||||||||||
| 2010-03-31 | $16.10M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |